Evidence map›Paper›PMID 38156408›Full record

SynthesisThe Journal of international medical research2023

Is endoscopic radiofrequency ablation plus stent placement superior to stent placement alone for the treatment of malignant biliary obstruction? A systematic review and meta-analysis.

Chenming Liu, Jiaming Dong, Yuxing Liu, Siyuan Zhang, Ruanchang Chen, Haijun Tang

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The Journal of international medical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Sequential central retinal artery occlusion in two brothers: a fight to prevent blindness.Documenta ophthalmologica. Advances in ophthalmology · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Chenming LiuDepartment of Hepatopancreatobiliary Surgery, Shaoxing People's Hospital, Shaoxing, PR China.ORCID 0009-0003-3622-0400
Jiaming DongDepartment of Hepatopancreatobiliary Surgery, Shaoxing People's Hospital, Shaoxing, PR China.
Yuxing LiuDepartment of Colorectal and Anal Surgery, Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, PR China.ORCID 0009-0008-7564-0092
Siyuan ZhangDepartment of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, PR China.
Ruanchang ChenDepartment of Hepatopancreatobiliary Surgery, Shaoxing People's Hospital, Shaoxing, PR China.
Haijun TangDepartment of Hepatopancreatobiliary Surgery, Shaoxing People's Hospital, Shaoxing, PR China.
Shaoxing People's Hospital · CNShaoxing University · CNJinzhou Medical University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMalignant biliary obstruction (MBO) is a rare disease with a poor prognosis. Recent studies have shown that endoscopic radiofrequency ablation (ERFA) may improve survival. We conducted a systematic review and meta-analysis of the efficacy of ERFA in combination with biliary stent placement for the treatment of MBO.

methodsThe study was registered in INPLASY (number 202340096). The PubMed, Cochrane Library, Web of Science, and Embase databases were searched from inception to April 2023. We selected studies comparing the efficacy of ERFA plus stent placement with stent placement alone. The primary outcomes were pooled hazard ratios (HRs) for overall survival and stent patency; the secondary outcomes were the odds ratios (ORs) for adverse events.

resultsEleven studies (four randomized controlled trials and seven observational studies) were included in the meta-analysis. Pooled analysis showed a difference in survival time between the two groups (HR 0.65, 95% confidence interval [CI] 0.58-0.73,

conclusionsERFA has a significant survival benefit for MBO, but does not increase the risk of adverse events.

Indexed as

Bile Duct NeoplasmsCholestasisRadiofrequency AblationStentsEndoscopyHumansTreatment Outcomeadverse eventendoscopic radiofrequency ablationmalignant biliary obstructionMeta-analysisstent patencysurvival

Identifiers

PMID38156408
PMCPMC10757445
OpenAlexW4390398919

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.